The consolidated net sales for the fiscal year ending March 2026 were 418.99 billion yen (up 3.4% YoY), operating income was 2.919 billion yen (down 2.7% YoY), and net income attributable to owners of parent was 3.708 billion yen (up 66.5% YoY).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4549","jir_company_name":"Eiken Chemical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4549-20260512-01.pdf","jir_short_summary":"The consolidated net sales for the fiscal year ending March 2026 were 418.99 billion yen (up 3.4% YoY), operating income was 2.919 billion yen (down 2.7% YoY), and net income attributable to owners of parent was 3.708 billion yen (up 66.5% YoY).","jir_summary":"### Performance Overview\nThe consolidated net sales for the fiscal year ending March 2026 were 41,899 billion yen (up 3.4% YoY), maintaining steady growth. Although sales of microbiological testing reagents declined, overseas sales of urine test reagents and fecal blood test reagents increased, and steady performance of products introduced and sold from Toso Corporation contributed to revenue growth. Operating income was 2.919 billion yen (down 2.7%), and ordinary income was 2.844 billion yen (down 11.1%). However, due to the recording of special gains associated with the transfer of stakes in consolidated subsidiaries, net income attributable to owners of parent surged to 3.708 billion yen (up 66.5%), reflecting substantial profit growth.\n\n### Financial Position and Dividend Situation\nTotal assets amounted to 62,657 billion yen, net assets stood at 44,034 billion yen, both increasing YoY, and the equity ratio improved to 70.1%. Regarding dividends, the annual dividend for the fiscal year ending March 2026 is planned at 58 yen per share (up from 53 yen), with a payout ratio of 51.5%. The dividend forecast for the fiscal year ending March 2027 also remains at 58 yen annually.\n\n### Earnings Guidance for Fiscal Year Ending March 2027\nSales are projected to be 42,000 billion yen (up 0.2% YoY), operating income 3.070 billion yen (up 5.2%), ordinary income 2.900 billion yen (up 2.0%), and net income attributable to owners of parent 2.070 billion yen (down 44.2%). While expecting increased sales of fecal blood test reagents in overseas markets and ongoing efforts to enhance profitability, a decrease in net income is forecasted due to the reversal of special gains recorded in the previous year.","jir_financial_highlights":"Net Sales: 41,899 billion yen (Up 3.4% YoY)\nOperating Income: 2,919 million yen (Down 2.7% YoY)\nOrdinary Income: 2,844 million yen (Down 11.1% YoY)\nNet Income Attributable to Owners of Parent: 3,708 million yen (Up 66.5% YoY)\nEarnings Per Share: 112.52 yen (Increased from 64.82 yen YoY)\nTotal Assets: 62,657 billion yen (Increase YoY (62,372 billion yen))\nNet Assets: 44,034 billion yen (Increase YoY (43,598 billion yen))\nEquity Ratio: 70.1% (Increased from 69.3% YoY)\nAnnual Dividends: 58 yen (Increase from 53 yen YoY)\nNumber of Outstanding Shares (Common Stock): 34,541,438 shares (Decrease from 38,541,438 shares YoY)","jir_category":"","jir_hashtags":"#EikenChemical, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Net sales: 41,899 billion yen (up 3.4% YoY)\nNet income attributable to owners of parent: 3.708 billion yen (up 66.5% YoY)\nAnnual dividends: 58 yen (up from 53 yen)\nEquity ratio: 70.1% (up from 69.3%)\nNumber of outstanding shares: 34,541,438 shares (down from 38,541,438 shares)","jir_meta_title":"\u3010Eiken Chemical\u3011Fiscal Year Ending March 2026 Results\uff5cSales of 41.8 billion yen (+3.4% YoY), Net Profit Increased by 3.7 billion yen","jir_meta_description":"Eiken Chemical Co., Ltd.'s fiscal year ending March 2026 financial summary. Net sales of 41,899 billion yen (up 3.4% YoY), net income attributable to owners of parent of 3.708 billion yen (up 66.5%). Annual dividend of 58 yen planned.","jir_og_title":"\u3010Eiken Chemical\u3011Fiscal Year Ending March 2026 Results\uff5cSales of 41.8 billion yen (+3.4%), Net Profit of 3.7 billion yen Increase","jir_og_description":"Eiken Chemical's fiscal year ending March 2026 financial summary. Net sales of 41,899 billion yen, net income of 3,708 billion yen, both increase. Dividends of 58 yen planned.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY ended March 2022\\\",\\\"FY ended March 2023\\\",\\\"FY ended March 2024\\\",\\\"FY ended March 2025\\\",\\\"FY ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[\\\"Unknown\\\",\\\"Unknown\\\",\\\"40,539\\\",\\\"40,539\\\",\\\"41,899\\\"],\\\"borderColor\\\":\\\"#007bff\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY ended March 2022\\\",\\\"FY ended March 2023\\\",\\\"FY ended March 2024\\\",\\\"FY ended March 2025\\\",\\\"FY ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[\\\"Unknown\\\",\\\"Unknown\\\",\\\"Unknown\\\",\\\"2,999\\\",\\\"2,919\\\"],\\\"borderColor\\\":\\\"#28a745\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_income_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY ended March 2022\\\",\\\"FY ended March 2023\\\",\\\"FY ended March 2024\\\",\\\"FY ended March 2025\\\",\\\"FY ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[\\\"Unknown\\\",\\\"Unknown\\\",\\\"Unknown\\\",\\\"2,228\\\",\\\"3,708\\\"],\\\"borderColor\\\":\\\"#dc3545\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"dividend_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Annual Dividends (Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY ending March 2024\\\",\\\"FY ending March 2025\\\",\\\"FY ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Annual Dividends\\\",\\\"data\\\":[\\\"Unknown\\\",\\\"53\\\",\\\"58\\\"],\\\"backgroundColor\\\":\\\"#ffc107\\\"}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"equity_ratio_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Equity Ratio Trend (%)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY ending March 2022\\\",\\\"FY ending March 2023\\\",\\\"FY ending March 2024\\\",\\\"FY ending March 2025\\\",\\\"FY ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Equity Ratio\\\",\\\"data\\\":[72.8,74.2,74.0,69.3,70.1],\\\"borderColor\\\":\\\"#17a2b8\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true,\\\"max\\\":100}}}}\"}]","ir_related_company":16754,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-46885","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n